Answers are grounded in this paper and cite their sources.
Evaluates tumor uptake of engineered antibody constructs, suggesting improved targeting vectors for cancer imaging.
properties, F7 was engineered into three formats: a monomer (F7), a tethered dimer (F7D), and an Fc-fusion protein (F7-Fc). All three were specific for FAP with the two bivalent constructs demonstrating picomolar affinity. Positron emission tomography imaging in FAP-positive xenograft models revealed distinct pharmacokinetic profiles across constructs, with notable differences in tumor uptake and clearance. F7 had rapid uptake and clearance, resulting in significantly higher tumor uptake than FAPI-46. Low molecular weight bivalent F7D demonstrated similar kinetics but was retained by the tumor, resulting in a high tumor-to-blood ratio with secondary uptake limited to clearance organs. The largest construct, F7-Fc, resulted in the highest tumor uptake and allowed for longitudinal imaging. Absorbed dose calculations confirmed that tumors received significantly higher radiation doses compared to normal tissues. These findings demonstrate that tuning VHH scaffold size and valency can improve biodistribution and retention, establishing F7-based constructs as promising targeting vectors for FAP.
No takes yet. Share an insight, caveat, or question.
Gallant et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: